Insights

We're always on the move, staying informed, inspired, and ahead of the curve in the ever-evolving medical communications space. Here, you'll find a collection of posts that dive deep into the trends, challenges, and innovations shaping healthcare today.

Our Key Takeaways from Fierce Pharma Week

Fierce Pharma Week (Fierce) was buzzing with artificial intelligence (AI) demos, omnichannel promises, and bold predictions. Above all of the chatter, a clear theme rose to the top: pharma's future will be shaped not by who shouts the loudest, but by who delivers the most credible, relevant, and timely content to healthcare professionals (HCPs).

AMCP 2026 managed care value evidence access takeaways

Takeaways From AMCP 2026: Redefining Value, Evidence, and Access in a Rapidly Evolving Market

As managed care leaders, payers, and manufacturers gathered in Nashville for AMCP 2026, discussions reflected a healthcare landscape in transition—shaped by evolving policy, accelerating innovation, and increasing system complexity.

ACC.26 American College of Cardiology annual session takeaways

Our Takeaways From ACC.26

The American College of Cardiology Annual Scientific Session (ACC.26), held last month in New Orleans, Louisiana, was keenly focused on innovation and multisystem care, and reinforced cardiology's transition into a data-rich, technology-enabled, multidisciplinary specialty. Priority topics included artificial intelligence (AI) integration, late-breaking science, multisystem disease management, and real-world application of guidelines—while also elevating team-based care and clinician sustainability.

Speaker Programs Summit 2026 compliance takeaways

Our Takeaways From the Speaker Programs Summit 2026

This year's summit, held March 2-4 in Philadelphia, assembled agency partners, pharmaceutical teams, and legal/compliance experts for an exploration of the trends in program types, compliance guardrails, and the use of technology to help ensure program quality.

CTAD 2025 Alzheimer's disease therapeutics takeaways

Takeaways from CTAD 2025: Continued Evolution of AD Therapeutics

As the cold tendrils of winter began to creep into memory and dementia clinics across the United States, Alzheimer's disease (AD) clinicians and researchers headed to sunny San Diego for the Clinical Trials on Alzheimer's Disease 2025 (CTAD25) conference.

NEI 2025 Fall Congress psychiatry insights

NEI 2025 Fall Congress: Key Themes and Insights

The 2025 NEI Fall Congress, held at The Broadmoor, brought together leading voices in psychiatry to discuss the field's rapid evolution.

Psych Congress 2025: Key Takeaways

We are excited to share the highlights from last week's Psych Congress 2025 where leading experts in psychiatry gathered in San Diego to discuss the latest advancements in the field. This year's key themes centered on emerging topics, such as developing novel therapeutics for treating schizophrenia, targeting the glutamate neurotransmitter system for treating mood disorders, using blood-based biomarkers for treating Alzheimer's disease, and addressing the rise of prescription digital therapeutics.